Insufficient scRNA-seq data for expression of ITGAD at single-cell level.
Insufficient scRNA-seq data for expression of ITGAD at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 92% | 76.91 | 208 / 226 | 19% | 0.97 | 77 / 406 |
lung | 93% | 62.99 | 539 / 578 | 13% | 0.24 | 150 / 1155 |
spleen | 100% | 2327.07 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 95% | 43.93 | 765 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 166.66 | 779 / 929 | 0% | 0 | 0 / 0 |
breast | 66% | 16.69 | 303 / 459 | 17% | 0.36 | 193 / 1118 |
adipose | 81% | 36.99 | 978 / 1204 | 0% | 0 | 0 / 0 |
bladder | 76% | 31.86 | 16 / 21 | 4% | 0.16 | 21 / 504 |
kidney | 35% | 9.08 | 31 / 89 | 43% | 1.92 | 387 / 901 |
uterus | 61% | 25.52 | 104 / 170 | 11% | 0.26 | 50 / 459 |
heart | 71% | 15.44 | 615 / 861 | 0% | 0 | 0 / 0 |
intestine | 61% | 19.35 | 585 / 966 | 4% | 0.13 | 21 / 527 |
stomach | 52% | 10.84 | 187 / 359 | 8% | 0.14 | 23 / 286 |
lymph node | 0% | 0 | 0 / 0 | 59% | 2.57 | 17 / 29 |
esophagus | 54% | 13.92 | 781 / 1445 | 3% | 0.06 | 5 / 183 |
prostate | 53% | 10.82 | 130 / 245 | 3% | 0.06 | 16 / 502 |
skin | 25% | 4.26 | 446 / 1809 | 28% | 0.86 | 134 / 472 |
ovary | 47% | 20.11 | 84 / 180 | 5% | 0.12 | 23 / 430 |
thymus | 31% | 12.43 | 202 / 653 | 14% | 0.42 | 87 / 605 |
blood vessel | 34% | 17.78 | 455 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 25% | 4.17 | 65 / 258 | 6% | 0.10 | 13 / 230 |
tonsil | 0% | 0 | 0 / 0 | 22% | 0.50 | 10 / 45 |
brain | 19% | 3.45 | 497 / 2642 | 3% | 0.09 | 20 / 705 |
pancreas | 9% | 1.28 | 31 / 328 | 7% | 0.14 | 12 / 178 |
eye | 0% | 0 | 0 / 0 | 10% | 0.25 | 8 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006955 | Biological process | immune response |
GO_0007229 | Biological process | integrin-mediated signaling pathway |
GO_0033627 | Biological process | cell adhesion mediated by integrin |
GO_0034113 | Biological process | heterotypic cell-cell adhesion |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0007160 | Biological process | cell-matrix adhesion |
GO_0009986 | Cellular component | cell surface |
GO_0008305 | Cellular component | integrin complex |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0046872 | Molecular function | metal ion binding |
GO_0005178 | Molecular function | integrin binding |
Gene name | ITGAD |
Protein name | Integrin alpha-D (ADB2) (CD11 antigen-like family member D) (Leukointegrin alpha D) (CD antigen CD11d) |
Synonyms | |
Description | FUNCTION: Integrin alpha-D/beta-2 is a receptor for ICAM3 and VCAM1. May play a role in the atherosclerotic process such as clearing lipoproteins from plaques and in phagocytosis of blood-borne pathogens, particulate matter, and senescent erythrocytes from the blood. |
Accessions | ENST00000389202.3 Q13349 |